Get my own profile
Public access
View all56 articles
7 articles
available
not available
Based on funding mandates
Co-authors
- mark-david levinVerified email at asz.nl
- Henrik FrederiksenConsultant of Haematology, Associate Professor, Odense University HospitalVerified email at rsyd.dk
- Arne KolstadMD PhD, Department of Oncology, Oslo University HospitalVerified email at ous-hf.no
- Stephan StilgenbauerProfessor of Medicine, Ulm University, Ulm, GermanyVerified email at uniklinik-ulm.de
- Klaus RostgaardSenior Statistician, Statens Serum InstitutVerified email at ssi.dk
- Martin HutchingsRigshospitaletVerified email at rh.regionh.dk
- Marie HellebergDepartment of Infectious Diseases, Copenhagen University Hospital, RigshospitaletVerified email at regionh.dk
- Simon HusbyMD, PhD, RigshospitaletVerified email at regionh.dk
- Nakhle SabaTulane UniversityVerified email at tulane.edu
- Andrew H. Lipsky, M.D.Columbia UniversityVerified email at cumc.columbia.edu
- Inhye E. AhnDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Davide RossiOncology Institute of Southern SwitzerlandVerified email at eoc.ch
- Gunnar PejlerUppsala UniversityVerified email at imbim.uu.se
- Angelique BiancottoSanofiVerified email at sanofi.com
- Neal YoungNIHVerified email at mail.nih.gov
- Nicholas ChiorazziThe Feinstein Institute for Medical ResearchVerified email at Northwell.edu
- john C. ByrdDistinguished University Professor, The Ohio State UniversityVerified email at osumc.edu
- Amy J JohnsonVincerx PharmaVerified email at vincerx.com
- Jakob Werner HansenRigshospitalet, University of CopenhagenVerified email at regionh.dk
- Magnus AbrinkVerified email at slu.se